ATE170513T1 - Diastereomeres salz von optisch aktiver chinolinmevalonsäure - Google Patents
Diastereomeres salz von optisch aktiver chinolinmevalonsäureInfo
- Publication number
- ATE170513T1 ATE170513T1 AT92110636T AT92110636T ATE170513T1 AT E170513 T1 ATE170513 T1 AT E170513T1 AT 92110636 T AT92110636 T AT 92110636T AT 92110636 T AT92110636 T AT 92110636T AT E170513 T1 ATE170513 T1 AT E170513T1
- Authority
- AT
- Austria
- Prior art keywords
- optically active
- diastereomeric salt
- quinolinemevalonic acid
- active quinolinemevalonic
- acid
- Prior art date
Links
- KFPZNZVASUJWQQ-AWKYBWMHSA-N C1=CC=CC2=NC(C(O)C[C@](O)(C)CC(O)=O)=CC=C21 Chemical compound C1=CC=CC2=NC(C(O)C[C@](O)(C)CC(O)=O)=CC=C21 KFPZNZVASUJWQQ-AWKYBWMHSA-N 0.000 title abstract 2
- 150000003839 salts Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP15181091 | 1991-06-24 | ||
| JP12727792A JP3528186B2 (ja) | 1991-06-24 | 1992-05-20 | 光学活性キノリンメバロン酸のジアステレオマー塩 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE170513T1 true ATE170513T1 (de) | 1998-09-15 |
Family
ID=26463266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT92110636T ATE170513T1 (de) | 1991-06-24 | 1992-06-24 | Diastereomeres salz von optisch aktiver chinolinmevalonsäure |
Country Status (10)
| Country | Link |
|---|---|
| US (3) | US5284953A (de) |
| EP (2) | EP0742209A3 (de) |
| JP (1) | JP3528186B2 (de) |
| KR (1) | KR100208867B1 (de) |
| AT (1) | ATE170513T1 (de) |
| CA (1) | CA2072162C (de) |
| DE (1) | DE69226822T2 (de) |
| DK (1) | DK0520406T3 (de) |
| ES (1) | ES2120973T3 (de) |
| TW (1) | TW293007B (de) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU691582B2 (en) * | 1994-02-25 | 1998-05-21 | Daicel Chemical Industries Ltd. | Process for producing optically active mevalonolactone compound |
| KR100431038B1 (ko) | 1995-07-17 | 2004-05-12 | 워너-램버트 캄파니 엘엘씨 | 결정질[ｒ-(ｒ*,ｒ*)]-2-(4-플루오로페닐)-베타,델타-디히드록시-5-(1-메틸에틸)-3-페닐-4-[(페닐아미노)카르보닐]-1ｈ-피롤-1-헵탄산 헤미 칼슘염 (아토르바스타틴) |
| DE69625046T2 (de) * | 1995-12-22 | 2003-04-10 | Kowa Co., Ltd. | Pharmazeutische zusammensetzung stabilisiert mit einem basischen medium |
| GB9614804D0 (en) * | 1996-07-15 | 1996-09-04 | Chiroscience Ltd | Resolution process |
| EP1054860B1 (de) | 1997-12-19 | 2007-04-25 | Pfizer Ireland Pharmaceuticals | Verfahren zur herstellung von 1,3-diolen |
| US6335449B1 (en) | 1998-07-23 | 2002-01-01 | Nissan Chemical Industries, Ltd. | Process for the preparation of quinoline derivative and intermediate therefor |
| KR100311645B1 (ko) * | 1999-12-24 | 2001-10-12 | 이홍천 | 간판 |
| GB0003305D0 (en) | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
| SK287922B6 (sk) * | 2001-04-05 | 2012-04-03 | Nissan Chemical Industries, Ltd. | Method for preparing a 7-qunolinyl-3,5-dihydroxyhept-6-enoate |
| JP4783998B2 (ja) * | 2001-05-15 | 2011-09-28 | 宇部興産株式会社 | （３ｒ，５ｓ）−７−置換−３，５−ジヒドロキシヘプト−６−エン酸の製法 |
| WO2003027073A1 (fr) * | 2001-09-19 | 2003-04-03 | Ube Industries, Ltd. | Procede de production d'ester optiquement actif d'acide 7-{2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl}-3,5-dihydroxyhept-6-enoique |
| US6835838B2 (en) * | 2002-01-28 | 2004-12-28 | Novartis Ag | Process for the manufacture of organic compounds |
| PL370658A1 (en) | 2002-01-31 | 2005-05-30 | Novartis Ag | Process for the manufacture of hmg-coa reductase inhibitors |
| KR101067314B1 (ko) * | 2002-09-20 | 2011-09-23 | 닛산 가가쿠 고교 가부시키 가이샤 | 3,5-디하이드록시-6-헵테노에이트 제조 방법 |
| CN101219992B (zh) * | 2003-02-12 | 2011-08-31 | 日产化学工业株式会社 | 匹伐他汀钙的晶形 |
| US20060276486A1 (en) * | 2003-04-17 | 2006-12-07 | Kowa Co., Ktd. | Lklf/klf2 gene expression promoter |
| WO2005077916A1 (en) * | 2004-01-19 | 2005-08-25 | Ranbaxy Laboratories Limited | Salts of hmg-coa reductase inhibitors and use thereof |
| JP2007512347A (ja) * | 2003-11-26 | 2007-05-17 | デューク・ユニバーシティー | 緑内障を予防するかまたは治療する方法 |
| TWI328006B (en) * | 2003-12-26 | 2010-08-01 | Nissan Chemical Ind Ltd | Crystal form of quinoline compound and process for its production |
| CN101220021B (zh) * | 2007-01-12 | 2010-12-08 | 上海医药工业研究院 | 4-取代苯氧基喹啉类化合物及其中间体、制备方法和应用 |
| WO2008111055A1 (en) * | 2007-03-12 | 2008-09-18 | In-Dot Ltd. | Color sensing for a reader device and the like |
| JP5533654B2 (ja) * | 2008-09-05 | 2014-06-25 | 日産化学工業株式会社 | ３，５−ジヒドロキシ−６−ヘプテン酸アミン塩類の製造方法 |
| US20120022102A1 (en) | 2010-01-20 | 2012-01-26 | Cadila Healthcare Limited | Method for preparation of pitavastatin and its pharmaceutical acceptable salts thereof |
| WO2012025939A1 (en) | 2010-08-25 | 2012-03-01 | Cadila Healthcare Limited | Pitavastatin calcium and process for its preparation |
| US8912333B2 (en) * | 2010-11-12 | 2014-12-16 | Hetero Research Foundation | Polymorphs of pitavastatin calcium |
| KR101270586B1 (ko) * | 2010-11-26 | 2013-06-03 | 주식회사 아미노로직스 | 광학적으로 순수한 2,2'-디히드록시-1,1'-바이나프틸-3-카르복실산의 제조방법 |
| WO2012140490A2 (en) | 2011-04-11 | 2012-10-18 | Aurobindo Pharma Limited | Process for preparing quinoline derivative |
| JP2011173912A (ja) * | 2011-04-28 | 2011-09-08 | Ube Industries Ltd | （３ｒ，５ｓ）−７−置換−３，５−ジヒドロキシヘプト−６−エン酸の製法 |
| EP2751081B1 (de) | 2011-09-12 | 2017-01-04 | Farma GRS, d.o.o. | Polymorphe form von pitavastatin kalzium |
| JP2013103884A (ja) * | 2011-11-10 | 2013-05-30 | Daito Kk | ピタバスタチンカルシウム塩の工業的製造方法 |
| CN102653523A (zh) * | 2011-12-17 | 2012-09-05 | 东莞达信生物技术有限公司 | 一种匹伐他汀钙重结晶制取方法 |
| WO2013098773A1 (en) * | 2011-12-28 | 2013-07-04 | Dr. Reddy's Laboratories Limited | Crystalline forms of pitavastatin calcium |
| CN102653524A (zh) * | 2012-01-12 | 2012-09-05 | 东莞达信生物技术有限公司 | 一种匹伐他汀钙中间体的制备方法 |
| EP2978743B1 (de) * | 2013-03-29 | 2019-11-27 | Centrient Pharmaceuticals Netherlands B.V. | Aminsalze von pravastatin und rosuvastatin |
| US9676729B2 (en) | 2013-03-29 | 2017-06-13 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Amine salts of pitavastatin and rosuvastatin |
| CN103508949B (zh) * | 2013-10-22 | 2015-12-09 | 黄河三角洲京博化工研究院有限公司 | 一种（e）-3-[2-环丙基-4-（4-氟-苯基）-3-喹啉基]丙烯醛的合成方法 |
| WO2016056658A1 (ja) * | 2014-10-10 | 2016-04-14 | 株式会社エーピーアイ コーポレーション | スタチン系化合物の精製方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH576445A5 (de) * | 1972-03-10 | 1976-06-15 | Ciba Geigy Ag | |
| US4567289A (en) * | 1979-08-17 | 1986-01-28 | Merck & Co., Inc. | Substituted pyranone inhibitors of cholesterol synthesis |
| CA1336714C (en) * | 1987-08-20 | 1995-08-15 | Yoshihiro Fujikawa | Quinoline type mevalonolactone inhibitors of cholesterol biosynthesis |
| DE3905908A1 (de) | 1989-02-25 | 1990-09-06 | Bayer Ag | Substituierte chinoline, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| FI94339C (fi) * | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
| DE3925636A1 (de) * | 1989-08-03 | 1991-02-07 | Bayer Ag | Imino-substituierte pyridine |
| EP0430129A3 (en) * | 1989-11-30 | 1992-02-26 | Tanabe Seiyaku Co., Ltd. | Novel phenylethylene derivatives, processes for preparing the same and intermediates therefor |
| JPH054943A (ja) * | 1990-08-30 | 1993-01-14 | Sagami Chem Res Center | 光学活性β，δ−ジケト酸エステル及びその還元体 |
-
1992
- 1992-05-20 JP JP12727792A patent/JP3528186B2/ja not_active Expired - Lifetime
- 1992-06-12 TW TW081104622A patent/TW293007B/zh active
- 1992-06-23 CA CA002072162A patent/CA2072162C/en not_active Expired - Lifetime
- 1992-06-23 US US07/902,863 patent/US5284953A/en not_active Expired - Lifetime
- 1992-06-24 EP EP96107815A patent/EP0742209A3/de not_active Withdrawn
- 1992-06-24 ES ES92110636T patent/ES2120973T3/es not_active Expired - Lifetime
- 1992-06-24 KR KR1019920011018A patent/KR100208867B1/ko not_active Expired - Lifetime
- 1992-06-24 DK DK92110636T patent/DK0520406T3/da active
- 1992-06-24 DE DE69226822T patent/DE69226822T2/de not_active Expired - Lifetime
- 1992-06-24 AT AT92110636T patent/ATE170513T1/de active
- 1992-06-24 EP EP92110636A patent/EP0520406B1/de not_active Expired - Lifetime
-
1993
- 1993-09-20 US US08/123,117 patent/US5473075A/en not_active Expired - Lifetime
-
1995
- 1995-05-25 US US08/450,383 patent/US5514804A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5473075A (en) | 1995-12-05 |
| KR100208867B1 (ko) | 1999-07-15 |
| CA2072162A1 (en) | 1992-12-25 |
| US5514804A (en) | 1996-05-07 |
| DE69226822T2 (de) | 1999-02-11 |
| CA2072162C (en) | 2002-11-19 |
| JP3528186B2 (ja) | 2004-05-17 |
| TW293007B (de) | 1996-12-11 |
| EP0742209A2 (de) | 1996-11-13 |
| EP0742209A3 (de) | 1997-05-14 |
| JPH05148237A (ja) | 1993-06-15 |
| KR930000486A (ko) | 1993-01-15 |
| ES2120973T3 (es) | 1998-11-16 |
| DK0520406T3 (da) | 1998-12-14 |
| EP0520406A1 (de) | 1992-12-30 |
| EP0520406B1 (de) | 1998-09-02 |
| US5284953A (en) | 1994-02-08 |
| DE69226822D1 (de) | 1998-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69226822D1 (de) | Diastereomeres Salz von optisch aktiver Chinolinmevalonsäure | |
| NO178969C (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive, substituerte kinazolinoner | |
| PT90377A (pt) | Processo para a preparacao de derivados do acido piridonocarboxilico com actividade optica | |
| FI101226B1 (fi) | Menetelmä lääkeaineena käyttökelpoisten 2-[2-(karbonyyli)pyrrolidin-4-yylitio]-6-(1-hydroksietyyli)-1-metyylikarbapen-2-eemi-3-karboksyylihappojohdannaisten valmistamiseksi | |
| DE69328962D1 (de) | Verfahren zur herstellng von cyano-methoxyiminomethylderivaten | |
| NO175529C (no) | Fremgangsmåte for rensing av tryptofan | |
| DK0501774T3 (da) | Fremstilling af substituerede tetrahydropyridiner | |
| FI101301B1 (fi) | Menetelmä terapeuttisesti käyttökelpoisten, N-substituoitujen heksahydroatsepiinijohdannaisten valmistamiseksi | |
| UA8357A1 (uk) | Спосіб оптичного поділу піранобензоксадіазольної сполуки | |
| DE69218414D1 (de) | Verfahren zur herstellung von trans-piperidin-2,5-dicarboxylaten | |
| DE69133494D1 (de) | Microbiologische Herstellung von L-Ascorbinsäure | |
| DE69833951D1 (de) | Verfahren zur herstellung von substituierten alkylaminen oder salzen davon | |
| EP0608693A3 (de) | Verfahren zur Herstellung von Folsäure. | |
| DE3889772D1 (de) | Verfahren zur Herstellung von 3,3-Diarylacrylsäureamiden. | |
| ATE311382T1 (de) | Verfahren zur herstellung von 2-carbamoyl- pyridinen | |
| DK0488345T3 (da) | Optisk aktive 1,4-dihydropyridinderivater og fremgangsmåder til fremstilling deraf | |
| DE59206973D1 (de) | Trocknungsverfahren zur Herstellung von Ascorbinsäure-2-Monophosphaten | |
| DE3887465D1 (de) | Verfahren zur Herstellung von Säureanhydriden. | |
| BR9405262A (pt) | Processo para a preparação de um ácido piridina-2,3-dicarboxílico | |
| ATE92500T1 (de) | Methode zur herstellung von indan-derivaten. | |
| DE2967648D1 (en) | Utilisation of 2-(n-(2,6-dichloro-phenyl)-n-allyl-amino)-imidazoline-(2) for the production of bradycardiac drugs | |
| ES2195309T3 (es) | Derivados de tetrahidrofurano. | |
| IT1224527B (it) | Solfonati di 2,3-epossialchilammonio otticamente attivi, procedimento per la loro produzione, erelativo impiego | |
| ATE197949T1 (de) | Verfahren zur herstellung von optisch aktivem (s)-(-)- und (r)-(+)- deoxyspergualin und zwischenprodukte dafür | |
| ES2085540T3 (es) | 2-(3-fenilpropil)hidrazinas, productos intermedios en y un procedimiento para la preparacion de las mismas, y su uso como medicamentos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |